InflaRx
IFRX
34 hedge funds and large institutions have $19.6M invested in InflaRx in 2025 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 6 closing their positions.
643% more call options, than puts
Call options by funds: $312K | Put options by funds: $42K
120% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 5
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
26% more funds holding
Funds holding: 27 → 34 (+7)
14% more capital inflows, than outflows
Capital inflows: $5.61M | Capital outflows: $4.94M
1.21% more ownership
Funds ownership: 27.65% → 28.86% (+1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Suvretta Capital Management
New York
|
+$1.8M |
| 2 |
6CM
683 Capital Management
New York
|
+$1.32M |
| 3 |
Morgan Stanley
New York
|
+$540K |
| 4 |
Two Sigma Investments
New York
|
+$505K |
| 5 |
DA
DCF Advisers
Greenwich,
Connecticut
|
+$197K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA Capital Management
Boston,
Massachusetts
|
-$2.64M |
| 2 |
Ikarian Capital
Dallas,
Texas
|
-$968K |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$444K |
| 4 |
Boothbay Fund Management
New York
|
-$235K |
| 5 |
ADAR1 Capital Management
Austin,
Texas
|
-$214K |
IFRX Hedge Fund Activity: Q4 2025 in Review
34 of the 8,303 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q4 2025, worth a combined $19.6M — down 21% from $24.9M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new IFRX positions and 6 closed out — a net gain of 7 holders — while 11 added to existing stakes and 5 trimmed.
The largest buyer was Suvretta Capital Management, adding an estimated $1.8M. The largest seller was RA Capital Management, exiting entirely with an estimated $2.64M sold.
- 34 institutional investors held InflaRx (IFRX) as of Q4 2025, up from 27 in Q3 2025.
- Funds reported $19.6M of InflaRx stock for Q4 2025, down 21% quarter-over-quarter.
- 13 funds opened new InflaRx positions in Q4 2025 and 6 closed out, a net change of +7 holders.
- The largest InflaRx buyer in Q4 2025 was Suvretta Capital Management, an estimated $1.8M added.
- The largest InflaRx seller in Q4 2025 was RA Capital Management, an estimated $2.64M sold.
Based on aggregated 13F filings for Q4 2025.